Literature DB >> 23817939

N-acetylcysteine in children with acute liver failure complicating dengue viral infection.

M P Senanayake1, M D C J P Jayamanne, I Kankananarachchi.   

Abstract

OBJECTIVES: To describe the outcome after administration of N-acetylcysteine (NAC) to seven children with nonparacetamol induced acute liver failure (ALF) complicating dengue infection.
METHODS: Clinical records of children with non paracetamol induced acute liver failure complicating severe dengue viral infection, were retrospectively analysed for clinical and biochemical outcome following treatment with NAC.
RESULTS: Seven patients between ages six months to twelve years with plasma leakage and circulatory compromise complicating dengue infection developed ALF. Three were exposed to prolonged shock prior to hospitalisation. NAC infusion (100 mg/kg) was administered as soon as ALF was diagnosed, based on low GCS scores, raised transaminases and prolonged prothrombin/INR. Full clinical and biochemical recovery occurred in all patients.
CONCLUSIONS: A successful outcome followed early administration of NAC to children with ALF complicating severe dengue infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817939     DOI: 10.4038/cmj.v58i2.5684

Source DB:  PubMed          Journal:  Ceylon Med J        ISSN: 0009-0875


  9 in total

1.  Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection.

Authors:  Anita K McElroy; Jessica R Harmon; Timothy Flietstra; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

Review 2.  Dengue and its effects on liver.

Authors:  Jayanta Samanta; Vishal Sharma
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

Review 3.  Inflammatory and oxidative stress in rotavirus infection.

Authors:  Carlos A Guerrero; Orlando Acosta
Journal:  World J Virol       Date:  2016-05-12

4.  The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.

Authors:  Philip T James; Zakari Ali; Andrew E Armitage; Ana Bonell; Carla Cerami; Hal Drakesmith; Modou Jobe; Kerry S Jones; Zara Liew; Sophie E Moore; Fernanda Morales-Berstein; Helen M Nabwera; Behzad Nadjm; Sant-Rayn Pasricha; Pauline Scheelbeek; Matt J Silver; Megan R Teh; Andrew M Prentice
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.798

Review 5.  Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Authors:  Victor C Gan
Journal:  Curr Treat Options Infect Dis       Date:  2014

6.  Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia.

Authors:  Julien Saison; Françoise Berger; Fanny Lebosse; Regis Audoual; Xavier Thomas; Mauricette Michallet
Journal:  Am J Case Rep       Date:  2014-01-12

7.  The many faces of the anti-COVID immune response.

Authors:  Santosha A Vardhana; Jedd D Wolchok
Journal:  J Exp Med       Date:  2020-06-01       Impact factor: 14.307

Review 8.  N-acetylcysteine for non-acetaminophen induced acute liver failure: A review.

Authors:  Shirley Xue Jiang; Trana Hussaini; Eric M Yoshida
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

Review 9.  Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure.

Authors:  Gebrehiwot Gebremedhin Tafere; Dawit Zewdu Wondafrash; Filmon Beyenne Demoz
Journal:  Hepat Med       Date:  2020-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.